#news #biotech CymaBay takes a peek at liver disease candidate data

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CymaBay takes a peek at liver disease candidate data .Small cap CymaBay Therapeutics has taken a look at its ongoing midstage test for its liver med seladelpar, and says it’s happy with what it sees.

from FierceBiotech: Biotech http://ift.tt/2ur9xau